Stakes are high as biopharma gathers for JPM
2023 was a bad year for deal-making, but will 2024 be better? Here are some key questions as the JPMorgan Healthcare Conference gets underway.
Source: mmm-online.com
Stay updated with breaking news from Maze Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2023 was a bad year for deal-making, but will 2024 be better? Here are some key questions as the JPMorgan Healthcare Conference gets underway.